press release-凯发k8国际娱乐官网入口

凯发k8国际娱乐官网入口-k8天生赢家一触发
about us
about us
green valley is an innovative chinese pharmaceutical company that pioneers carbohydrate drugs development and manufacturing in the world.
about green valley
our business
mission & vision
our culture
code of business ethics
gv-971
gv-971
here you can get access to more information of gv-971.
products
news reports
research highlights
milestones
scientific research information
scientific research information
originality is the soul of our innovation in scientific research. we are devoted to developing drugs and healthcare solutions that patients are in the greatest need of.
life sciences innovation
research parteners
news
news
here you can get access to the latest news reports of green valley.
press releases
news reports
social responsibility
careers
apart from the competitive compensation & benefits programs, we have developed a detailed benefits and perks scheme. we respect, appreciate and reward the contributions of every employee for their hard work and dedication.
salary and benefits
contact us
contact us
media contacts
凯发k8国际娱乐官网入口-k8天生赢家一触发
press releases

feature | gv-971 global multi-center phase iii clinical trial

novel drug treatment shows improved cognition in a phase 3 clinical trial in persons with mild-to-mo

gv-971 gets included in china national reimbursement drug list

gv-971 global phase iii clinical trial completes first patient dosed in greater china

sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids
all
all
2022
2021
2020
2019
2018
2017
2015
05-13
2022
2022-05-13
announcement on early termination of gv-971 global multi-center phase iii clinical trial
01-13
2022
2022-01-13
green valley obtains ind approval from u.s. fda for sodium oligomannate’s global phase ii clinical trial in treating parkinson’s disease
12-06
2021
2021-12-06
gv-971 gets included in china national reimbursement drug list
08-03
2021
2021-08-03
gv-971 global phase iii clinical trial completes first patient dosed in greater china
06-16
2021
2021-06-16
gv-971 global phase iii clinical trial officially initiates in greater china
02-08
2021
2021-02-08
gv-971 global phase iii clinical trial completes first patient dosed globally
11-06
2020
2020-11-06
gv-971 global multi-center phase iii clinical trial kicks-off patient enrollment process
07-17
2020
2020-07-17
green valley site kicks off construction on carbohydrate drug manufacturing facility in shanghai
网站地图